Benzocaine Topical Gel Recalled Due to Manufacturing Quality Defect
Keystone Industries recalls Ipana 20% Benzocaine Topical Gel due to a manufacturing quality issue. The bulk product was released from a mixing vessel with scratches despite Quality Unit rejection.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II pharmaceutical recall due to CGMP deviation with potential contamination risk from manufacturing defect. No illnesses or injuries reported.
Plain-English summary
Keystone Industries is recalling Ipana 20% Benzocaine Topical Gel, 28g (Lot BNZ-001646, expiration 11/26/2026) due to a Current Good Manufacturing Practice (CGMP) deviation.
During routine inspection of the mixing vessel, the Quality Unit identified scratches on the sides and bottom of the vessel. The product should have been rejected but was inadvertently released and shipped to customers. The product was distributed nationwide in the United States and Canada, as well as to the Dominican Republic, El Salvador, Honduras, and Qatar.
Benzocaine is a topical anesthetic. The scratched mixing vessel poses a potential quality and contamination risk. Consumers who have purchased this product should discontinue use and contact the manufacturer or their healthcare provider with questions.
The recalled product
- Product
- Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada.
- Manufacturer
- Keystone Industries
- Category
- Drug — Topical Anesthetic
- Hazard
- manufacturing-defect
- potential-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot No.: BNZ-001646
- Exp Date: 11/26/2026
- Keystone Item No. 03-35119
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27